SCHEMBL20207613

SCHEMBL20207613

CC(=O)c1nc(N2CCNCC2)cs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC2 Q92769 4/20 0.48
▸ HDAC1 Q13547 2/20 0.47
▸ HDAC3 O15379 1/20 0.47
▸ BAZ2A Q9UIF9 4/20 0.41
▸ CASP1 P29466 1/20 0.39
▸ CASP4 P49662 1/20 0.39
▸ CASP5 P51878 1/20 0.39
▸ ITGA2B P08514 3/20 0.39
▸ IKBKB O14920 1/20 0.39
▸ ITGB3 P05106 1/20 0.39
▸ HRH4 Q9H3N8 1/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ CYP3A4 P08684 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ HTR3E A5X5Y0 2/20 0.37
▸ HTR3B O95264 2/20 0.37
▸ HTR3A P46098 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31706029 0.84 HDAC2 (0.48) HDAC2HDAC1HDAC3CASP1CASP4
Hydrochloric Acid SCHEMBL31706290 0.82 KDM4E (0.50) HDAC2HDAC1HDAC3CASP1CASP4
SCHEMBL8025125 0.71 CA1 (0.40) HDAC2HDAC1HDAC3CASP1CASP4
SCHEMBL3946056 0.69 CA1 (0.41) HDAC2HDAC1HDAC3IKBKBKDM4E
SCHEMBL8257243 0.69 PRKCQ (0.57) KDM4ECYP3A4HSD17B10ALDH1A1MEN1
SCHEMBL192028 0.68 CA1 (0.46) HDAC2HDAC1HDAC3CASP1IKBKB
SCHEMBL5229175 0.68 BAZ2A (0.48) HDAC2HDAC3BAZ2AALDH1A1MEN1
SCHEMBL9371310 0.68 SORD (0.58) HRH4KDM4ECYP3A4HSD17B10ALDH1A1
SCHEMBL16775737 0.66 CASP1 (0.43) CASP1CASP4CASP5ITGA2BIKBKB
SCHEMBL4935859 0.66 MAPT (0.51) HDAC2HDAC1HDAC3ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018098296-A1 PIPERAZINE DERIVATIVES AS SELECTIVE HDAC1,2 INHIBITORS REGENACY PHARMACEUTICALS, LLC (US) 2018-05-31 — — WO disclosed
Send feedback